CD14 receptor occupancy in severe sepsis: Results of a phase I clinical trial with a recombinant chimeric CD14 monoclonal antibody (IC14)*Konrad Reinhart, John P. Pribble, Steven M. Opal et al.|Critical Care Medicine|2004Cited by 80